Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines

Despite the rapid deployment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines, the emergence of SARS-CoV-2 variants and reports of their immune evasion characteristics have led to an urgent need for novel vaccines that confer potent cross-protective immunity. In this study, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Cong, Yuan, Run-Yu, Xie, Chu, Sun, Jiu-Feng, Fang, Xin-Yan, Hu, Yi-Sha, Yu, Xiao-Hui, Liu, Zheng, Zeng, Mu-Sheng, Kang, Yin-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278117/
https://www.ncbi.nlm.nih.gov/pubmed/35699445
http://dx.doi.org/10.1128/jvi.00383-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278117/
https://www.ncbi.nlm.nih.gov/pubmed/35699445
http://dx.doi.org/10.1128/jvi.00383-22

Ejemplares similares